Series A Funding will be used to advance Mosanna's nasal spray therapy through Phase 2 Clinical TrialsBiotech veteran David ...

SAN DIEGO--(BUSINESS WIRE)--Scientist.com, the leading R&D procurement platform for the life sciences, today integrated Trial Insights™—its real‑time clinical‑trial analytics tool—into ...

Clinical trials are the foundation of modern medicine, guiding the development of safe and effective treatments for patients around the world. But when it comes to rare diseases—conditions that each ...

Carrie Madormo, RN, MPH, is a health writer. She has over a decade of experience as a registered nurse, practicing in a variety of fields, such as pediatrics, oncology, chronic pain, and public ...

In today’s globalized pharma environment, technical and supply chain challenges in the clinical trial process create ripple effects felt by stakeholders across regions and functions. This has ...

Expanding clinical ... to clinical trial research and participation, whether because they are members of a historically underrepresented group or live in a location that prevents easy access.

Previous retrospective findings suggested that elemental diets might reduce microbial overgrowth, yet no prospective clinical trials had tested this in patients with SIBO or IMO. Use of elemental ...

For kidney transplant recipient Janet Handal, the recent push to phase out COVID-19 research could have a deadly outcome. In early 2021, Handal participated in a study that found almost half of ...

A phase 2a clinical trial of NEO100-01 is continuing to recruit patients with malignant gliomas, with full enrollment expected in September. A phase 2a clinical trial of NEO100-01 is continuing to ...

Correspondence to Dr Thomas Bandholm, Dept of Clinical Research ... introduction by stating the aim or the objective of your trial and include the hypothesis. Aims and hypotheses are not always easy ...

The FDA placed a clinical hold on BioNTech’s Phase 1/2a trial for its investigational RNA-based malaria vaccine, BNT165e. BioNTech paused the study and is working with the FDA to address its ...

MIAMI--(BUSINESS WIRE)--Summit Therapeutics Inc. (NASDAQ: SMMT) today announced a clinical trial collaboration with Pfizer Inc. (NYSE: PFE) to evaluate ivonescimab, a novel, investigational PD-1 ...